Home

Elephant Head Communications

An independent strategic advisory and communications consultancy serving public and private life science, biotech and biopharma companies. 

Photo by Element5 Digital on Pexels

Hi, I’m Priyanka, founder of Elephant Head Communications.

I partner with company founders and early company leadership, serving as an advisor and counselor on developing their brand, voice, foundational messaging and overall corporate and investor communication strategies.

EHC is the right partner when your company is navigating stages of growth, whether emerging from stealth, preparing for an IPO, securing funding, or managing complex business milestones.

For early-stage companies that aren’t yet ready for a full-time head of communications or investor relations, I'm a thought partner that scales with your needs. I also work alongside in-house teams that require experienced leadership and expanded coverage. 

With a fractional model, I offer hands-on strategic guidance without the overhead of a full-time hire. When additional expertise is needed, from capital markets advisory to  technical web development, or other specialized areas, I bring in vetted senior consultants to ensure seamless execution.

My approach is outcome-driven and scalable, aligning communications with business objectives to help companies raise capital, secure partnerships, attract talent, and build market credibility.

Learn more about my background on LinkedIn. 

When is EHC the right partner for you?

  • Company Building: Stealth mode exit to building public presence.
  • Financings & M&A: IPOs/reverse mergers, funding rounds, BD agreements.
  • Drug Development: Medical meetings, journal publications, regulatory events.
  • Reputation Management: Data outcomes, regulatory actions, supply chain, and more.

Core offerings

  • Executive Counsel 
  • Corporate Disclosure Planning
  • Company Narrative/Thesis Development
  • Corporate Communications
  • Financial & Investor Communication
  • Corporate Transformations
  • Corporate Affairs Organization Design
  • Media Strategy & Public Relations
  • Executive Visibility
  • Speaker & Media Coaching
  • Corporate Brand Voice and Identity 
  • Issues & Crisis Management  
  • Commercial & Pipeline Communications

Select Client Work

SHY Therapeutics •

SHY Therapeutics | Company Launch & Brand Building

SHY Therapeutics engaged EHC shape the company’s identity and communications strategy as it began to establish a presence beyond stealth. Currently leading development of the corporate narrative, website, and foundational materials to position SHY’s differentiated science for credibility and visibility among strategic partners.

SHY is a private biotechnology company developing small molecule therapeutics that non-covalently target ATPases and GTPases.
Endpoints News •

ProfoundBio | Corporate Message Platform, Series B, M&A

ProfoundBio partnered with EHC for strategic corporate communications, encompassing the creation of a corporate messaging platform, including the development of its mission, vision, and values. EHC managed the company’s Series B announcement, providing executive media coaching and driving media relations efforts that secured high-quality placements in leading biotech and local Seattle outlets. Additionally, EHC supported M&A and integration communications following ProfoundBio’s acquisition by Genmab, ensuring seamless messaging and stakeholder alignment throughout the transition.
Endpoints News •

TCG Labs Soleil | Financing & Launch of New Venture Biotech Model

EHC serves as a strategic communications advisor to TCG Labs Soleil, supporting the launch of its $400M+ venture-biotech firm and helping shape its identity, messaging, and communications strategy. Providing ongoing counsel on portfolio storytelling, partnership announcements, and stakeholder visibility.

TCG Labs Soleil is a venture firm integrating dedicated capital with an in-house biotech R&D hub, forming and overseeing independent portfolio companies, each dedicated to single-asset programs, guiding them from ideation to clinical proof of concept and positioning them for strategic partnerships.

Let's connect.